Trademarkia Logo

Australia

AU$
RDRUG
Accepted: In opposition period

Last updated on 21 May 2025

Owner Info

Rgenta Therapeutics, Inc.

300 TradeCenter Drive, Suite 6600

Woburn MA 01801, UNITED STATES OF AMERICA

Serial Number

2545920 filed on 2 Apr 2025

Correspondent

Jessica L. Rothstein GOODWIN PROCTER LLP

620 Eighth Avenue,

New York NY 10018,

UNITED STATES OF AMERICA

RDRUG

Classification Information


Class [005]
Small molecule pharmaceutical preparations for use in cell and gene therapy for treating respiratory and infectious diseases and metabolic disorders, Read More

Mark Details


Serial Number

2545920

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

10 Oct 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
21st May 2025Application Accepted correspondence sent
20th May 2025IP Right has been Examined
20th May 2025IP Right Acceptance Published
20th May 2025Status change to Accepted
12th May 2025Awaiting examination
12th May 2025Examination expedited
8th May 2025IP Right Filed Published
8th May 2025Status change to Published
8th May 2025Status change to Filed
8th May 2025Application Received